Davie and Associates Dermatopathology P.A. v. Reditus Laboratories, LLC

2026 IL App (4th) 4241374
CourtAppellate Court of Illinois
DecidedJanuary 7, 2026
Docket4-42-41374
StatusPublished

This text of 2026 IL App (4th) 4241374 (Davie and Associates Dermatopathology P.A. v. Reditus Laboratories, LLC) is published on Counsel Stack Legal Research, covering Appellate Court of Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Davie and Associates Dermatopathology P.A. v. Reditus Laboratories, LLC, 2026 IL App (4th) 4241374 (Ill. Ct. App. 2026).

Opinion

FILED 2026 IL App (4th) 4241374 January 7, 2026 Carla Bender NOS. 4-24-1374, 4-25-0595 cons. 4th District Appellate Court, IL IN THE APPELLATE COURT

OF ILLINOIS

FOURTH DISTRICT

DAVIE AND ASSOCIATES DERMATOPATHOLOGY, ) Appeal from the P.A., ) Circuit Court of Plaintiff-Appellee, ) Tazewell County v. (No. 4-25-0595) ) REDITUS HEALTHCARE, LLC; AARON ROSSI; ) No. 21L19 REDITUS LABORATORIES, LLC; AJRMD ) MANAGEMENT COMPANY, INC.; AJR MD ) CONSULTING, LLC; AJR BRANDS, LLC; PR ) MANUFACTURING ENTERPRISES, LLC d/b/a PAL ) Health Technologies, LLC; RIVERWAY CRAFT ) LABORATORIES LLC; RIVERWAY PROPERTY ) MANAGEMENT, LLC; RT ACQUISITION & ) INVESTMENTS, LLC; LAWRENCE J. ROSSI JR., ) M.D.; TRICOUNTY ANESTHESIA, S.C.; MARK ) ROSSI; MICHAEL EVANS; MICHAEL EVANS LAW ) GROUP, LLC; MICHAEL EVANS, LTD.; JOHN S. ) ELIAS; JANAKI NAIR; and ELIAS MEGINNES & ) SEGHETTI, P.C., ) Defendants ) (Elias Meginnes & Seghetti, P.C.; John Elias; and Janaki ) Nair, ) Defendants-Appellants). ) ____________________________________________ ) ) REDITUS LABORATORIES, LLC, ) Plaintiff-Appellant, ) v. (No. 4-24-1374) ) JOHN ELIAS; JANAKI NAIR; ELIAS, MEGINNES & ) SEGHETTI, P.C.; and MARK ROSSI, ) No. 24L25 Defendants ) (John Elias; Janaki Nair; and Elias, Meginnes & Seghetti, ) Honorable P.C. ) Stephen A. Kouri, Defendants-Appellees). ) Judge Presiding JUSTICE LANNERD delivered the judgment of the court, with opinion. Justices Doherty and Harris concurred in the judgment and opinion.

OPINION

¶1 In February 2021, plaintiff, Davie and Associates Dermatopathology P.A.

(DAAD), a member of a Reditus Laboratories, LLC (Reditus), filed a complaint in Tazewell

County case No. 21-L-19 (the DAAD litigation) against Reditus and its other corporate members,

Aaron Rossi (Rossi) and Reditus Healthcare, LLC (Reditus Health), seeking an accounting and

judicial dissolution of Reditus. On February 3, 2022, DAAD filed a second amended complaint

asserting various breaches of fiduciary duty by Rossi, including a derivative claim on behalf of

Reditus. On February 13, 2022, DAAD sent a letter to one of Reditus’s attorneys, accusing its

attorneys—defendants John Elias, Janaki Nair, and Elais Meginnes & Seghetti, P.C. (collectively,

EMS)—of legal malpractice and aiding and abetting a breach of fiduciary duty. In December 2022,

DAAD filed a third amended complaint, adding derivative claims on behalf of Reditus against

EMS. Meanwhile, in April 2022, the trial court appointed a receiver for Reditus.

¶2 In April 2024, Reditus, through its receiver, filed a complaint in Tazewell County

case No. 24-L-25, alleging the same claims of legal malpractice and aiding and abetting a breach

of fiduciary duty against EMS and Reditus’s corporate counsel (the Reditus litigation). The trial

court granted EMS’s motion to dismiss, finding the action untimely under the two-year statute of

limitations. The court held the limitations period commenced when DAAD first threatened to file

suit against EMS, based on the same claims. The receiver argued the doctrine of adverse

domination applied and tolled the statute of limitations for claims by a company against its officers

while wrongdoing officers controlled the company. However, the court found EMS rebutted the

presumption that the adverse domination doctrine applied. Reditus appealed, which we docketed

as appellate court case No. 4-24-1374.

-2- ¶3 In case No. 21-L-19, the trial court granted the receiver’s motion to intervene and

found DAAD had standing to bring the derivative claims. EMS subsequently moved to dismiss,

alleging that, under principles of res judicata, the dismissal in case No. 24-L-25 as untimely also

required the dismissal of the claims in case No. 21-L-19. The court denied the motion, finding case

No. 21-L-19 had been timely filed. The court later entered an order certifying the following

question for our review: “Can a dismissal with prejudice on statute of limitations grounds have

res judicata effect on claims in another lawsuit that are timely filed?” We granted EMS’s

application for leave to appeal pursuant to Illinois Supreme Court Rule 308 (eff. Oct. 1, 2019),

which we docketed as appellate court case No. 4-25-0595. We later granted Reditus’s motion to

consolidate the two appeals.

¶4 In appeal No. 4-24-1374, we hold the adverse domination doctrine applies and

creates a rebuttable presumption and the trial court properly concluded EMS conclusively rebutted

the presumption when it showed DAAD had knowledge of the claim and the ability and motivation

to file suit as of February 2022.

¶5 In appeal No. 4-25-0595, we answer the certified question in the negative and

conclude a dismissal with prejudice on statute of limitations grounds generally would not have

res judicata effect on claims in another lawsuit that were timely filed because the causes of action

would ordinarily not be identical based on the factual differences in the dates the lawsuits were

filed, with one being timely and the other untimely. Additionally, the cases here were not identical

in time and origin. Under a pragmatic application of the transactional test and principles of

fundamental fairness, the trial court properly found res judicata did not apply to bar the DAAD

litigation.

¶6 Accordingly, we affirm in both cases.

-3- ¶7 I. BACKGROUND

¶8 The facts are derived from the complaints, which we take as true at the pleading

stage. Shrock v. Ungaretti & Harris Ltd., 2019 IL App (1st) 181698, ¶ 3. We also draw facts from

the various filings in both actions, including exhibits attached to the pleadings. Those pleadings

are in the records on appeal, and we may also judicially notice them. See id.

¶9 Reditus was organized in 2019 with two members—DAAD, owned by Dr. James

Davie, and Reditus Health, controlled by Rossi, who served as Reditus’s sole manager. During the

COVID-19 pandemic, Reditus secured lucrative contracts to perform polymerase chain reaction

testing with multiple government agencies, universities, and schools.

¶ 10 Rossi, using Reditus’s funds, acquired a 40% membership interest in PAL Health

Technologies, LLC (PAL), an orthotics manufacturer. The remaining ownership interests in PAL

were held by Dr. Gerald Paul and Paul’s brother, Rodney Bare. Rossi then funded some of

Reditus’s expenses with PAL’s funds, including payments for laboratory equipment and attorney

fees, and transferred $80,000 in cash from PAL to Reditus. As a result, in 2021, Paul, individually

and derivatively on behalf of PAL, filed a lawsuit (the Paul litigation) against Rossi.

¶ 11 EMS represented Rossi in the Paul litigation and in connection with a threat from

Bare to file similar litigation. EMS also represented Reditus at that time. Defendant Mark Rossi

was Reditus’s corporate counsel for a time but is not involved in this appeal.

¶ 12 In the spring of 2021, Rossi settled the Paul litigation and related disputes. Under

the settlement agreements, Bare was required to assign his interest in PAL to Rossi in exchange

for $2 million paid from Reditus, and Paul was required to assign his interest in PAL to Rossi in

exchange for $6.8 million, also paid from Reditus. Rossi did not list either payment as a debt owed

by him to Reditus and did not transfer either interest he received in PAL to Reditus.

-4- ¶ 13 Prior to January 1, 2021, Rossi had an employment agreement with Reditus, dated

December 2019, which was drafted by an attorney who is not a party to the current lawsuit. That

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Federal Deposit Insurance v. Smith
980 P.2d 141 (Oregon Supreme Court, 1999)
Resolution Trust Corp. v. Grant
1995 OK 68 (Supreme Court of Oklahoma, 1995)
Resolution Trust Corp. v. Smith
872 F. Supp. 805 (D. Oregon, 1995)
Hecht v. Resolution Trust Corp.
635 A.2d 394 (Court of Appeals of Maryland, 1994)
Wilson v. Paine
288 S.W.3d 284 (Kentucky Supreme Court, 2009)
Fisher v. Hamilton (In Re Teknek, LLC)
343 B.R. 850 (N.D. Illinois, 2006)
Lipscomb v. Sisters of St. Francis Health Services, Inc.
799 N.E.2d 293 (Appellate Court of Illinois, 2003)
Lease Resolution Corp. v. Larney
719 N.E.2d 165 (Appellate Court of Illinois, 1999)
Singer v. Brookman
578 N.E.2d 1 (Appellate Court of Illinois, 1991)
Greenfield v. Ray Stamm, Inc.
610 N.E.2d 118 (Appellate Court of Illinois, 1993)
Porter v. Decatur Memorial Hospital
882 N.E.2d 583 (Illinois Supreme Court, 2008)
River Park, Inc. v. City of Highland Park
703 N.E.2d 883 (Illinois Supreme Court, 1998)
Butts v. Estate of Butts
255 N.E.2d 622 (Appellate Court of Illinois, 1980)
Avery v. Auto-Pro, Inc.
731 N.E.2d 319 (Appellate Court of Illinois, 2000)
Walker v. Carnival Cruise Lines, Inc.
889 N.E.2d 687 (Appellate Court of Illinois, 2008)
Scottsdale Insurance Co. v. Lakeside Community Committee
2016 IL App (1st) 141845 (Appellate Court of Illinois, 2017)
Shrock v. Ungaretti & Harris Ltd.
2019 IL App (1st) 181698 (Appellate Court of Illinois, 2019)
Alexander v. Sanford
325 P.3d 341 (Court of Appeals of Washington, 2014)
Shrock v. Union National Bank
2021 IL App (1st) 200653-U (Appellate Court of Illinois, 2021)
Schultz v. Bank of Lyons
384 N.E.2d 113 (Appellate Court of Illinois, 1978)

Cite This Page — Counsel Stack

Bluebook (online)
2026 IL App (4th) 4241374, Counsel Stack Legal Research, https://law.counselstack.com/opinion/davie-and-associates-dermatopathology-pa-v-reditus-laboratories-llc-illappct-2026.